{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T11:42:19Z","timestamp":1788954139074,"version":"build-2803163510"},"reference-count":32,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T00:00:00Z","timestamp":1694476800000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,6,20]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Stroke prevention is central to the management of atrial fibrillation (AF), but there remains a residual risk of adverse outcomes in anticoagulated AF patients. Hence, current guidelines have proposed a more holistic or integrated approach to AF management, based on the Atrial fibrillation Better Care (ABC) pathway, as follows: (A) avoid stroke with anticoagulation; (B) better symptom control with patient-centred symptom directed decisions on rate or rhythm control; and (C) cardiovascular and comorbidity management, including lifestyle factors. There has been no formal healthcare cost analysis from the UK National Health Service (NHS) perspective of ABC pathway implementation to optimize the management of AF. Our aim was to estimate the number of patients with AF in the UK each year up to 2040, their morbidity and mortality, and the associated healthcare costs, and secondly, to estimate improvements in morbidity and mortality of implementing an ABC pathway, and the impact on costs.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>In 2020, there were an estimated 1\u2009463\u2009538 AF patients, resulting in \u00a3286\u00a0million of stroke care and \u00a3191\u00a0million of care related to bleeds annually. By 2030, it is expected that there will be 2\u2009115\u2009332 AF patients, resulting in \u00a3666\u00a0million of stroke healthcare and \u00a3444\u00a0million of healthcare related to bleeds. By 2040, this is expected to rise to 2\u2009856\u2009489 AF patients, with \u00a31096\u00a0million of stroke healthcare and \u00a3731\u00a0million of healthcare related to bleeds for that year. If in 2040 patients are managed on an ABC pathway, this could prevent between 3724 and 18\u2009622 strokes and between 5378 and 26\u2009890 bleeds, and save between 16\u2009131 and 80\u2009653 lives depending on the proportion of patients managed on the pathway. This would equate to cost reductions of between \u00a3143.9\u00a0million and \u00a3719.6\u00a0million for the year.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>We estimate that there will be a substantial healthcare burden in the UK NHS associated with AF, from strokes, bleeds, and mortality over the next decades. If patients are managed with a holistic or integrated care approach based on the ABC pathway, this could prevent strokes and bleeds that equate to substantial NHS healthcare cost reductions, and save lives.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ehjqcco\/qcad055","type":"journal-article","created":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T05:53:14Z","timestamp":1694497994000},"page":"326-333","source":"Crossref","is-referenced-by-count":29,"title":["Estimating the impact of implementing an integrated care management approach with Atrial fibrillation Better Care (ABC) pathway for patients with atrial fibrillation in England from 2020 to 2040"],"prefix":"10.1093","volume":"10","author":[{"given":"Elizabeth M","family":"Camacho","sequence":"first","affiliation":[{"name":"Institute of Population Health, University of Liverpool , UK"},{"name":"Liverpool Centre for Cardiovascular Science at University of Liverpool, Liverpool John Moores University and Liverpool Heart & Chest Hospital , Liverpool , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7566-1626","authenticated-orcid":false,"given":"Gregory Y H","family":"Lip","sequence":"additional","affiliation":[{"name":"Liverpool Centre for Cardiovascular Science at University of Liverpool, Liverpool John Moores University and Liverpool Heart & Chest Hospital , Liverpool , UK"},{"name":"Danish Center for Health Services Research, Department of Clinical Medicine, Aalborg University , Aalborg , Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,9,11]]},"reference":[{"key":"2024062010205619100_bib1","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1055\/a-1541-3885","article-title":"Risk of ischemic stroke in asymptomatic atrial fibrillation incidentally detected in primary care compared with other clinical presentations","volume":"122","author":"Wallenhorst","year":"2022","journal-title":"Thromb Haemost"},{"key":"2024062010205619100_bib2","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1093\/ehjqcco\/qcaa093","article-title":"Atrial fibrillation in the UK: predicting costs of an emerging epidemic recognizing and forecasting the cost drivers of atrial fibrillation-related costs","volume":"8","author":"Burdett","year":"2022","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"2024062010205619100_bib3","doi-asserted-by":"crossref","first-page":"e002197","DOI":"10.1161\/JAHA.115.002197","article-title":"Cause of death and predictors of all-cause mortality in anticoagulated patients with nonvalvular atrial fibrillation: data From ROCKET AF","volume":"5","author":"Pokorney","year":"2016","journal-title":"J Am Heart Assoc"},{"key":"2024062010205619100_bib4","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1055\/s-0041-1739411","article-title":"2021 Focused update consensus guidelines of the Asia Pacific Heart Rhythm Society on stroke prevention in atrial fibrillation: executive summary","volume":"122","author":"Chao","year":"2022","journal-title":"Thromb Haemost"},{"key":"2024062010205619100_bib5","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","article-title":"2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): the Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC","volume":"42","author":"Hindricks","year":"2021","journal-title":"Eur Heart J"},{"key":"2024062010205619100_bib6","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1055\/s-0040-1716408","article-title":"The 4S-AF scheme (stroke risk; symptoms; severity of burden; substrate): a novel approach to in-depth characterization (rather than classification) of atrial fibrillation","volume":"121","author":"Potpara","year":"2021","journal-title":"Thromb Haemost"},{"key":"2024062010205619100_bib7","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/nrcardio.2017.153","article-title":"The ABC pathway: an integrated approach to improve AF management","volume":"14","author":"Lip","year":"2017","journal-title":"Nat Rev Cardiol"},{"key":"2024062010205619100_bib8","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1055\/a-1515-9630","article-title":"Adherence to the \u2018Atrial fibrillation Better Care\u2019 pathway in patients with atrial fibrillation: impact on clinical outcomes: a systematic review and meta-analysis of 285,000 patients","volume":"122","author":"Romiti","year":"2022","journal-title":"Thromb Haemost"},{"key":"2024062010205619100_bib9","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1093\/europace\/euac082","article-title":"Evaluation of the atrial fibrillation better care pathway in the ENGAGE AF-TIMI 48 trial","volume":"24","author":"Patel","year":"2022","journal-title":"Europace"},{"key":"2024062010205619100_bib10","doi-asserted-by":"crossref","first-page":"e014932","DOI":"10.1161\/JAHA.119.014932","article-title":"Comprehensive management with the ABC (Atrial fibrillation Better Care) pathway in clinically complex patients with atrial fibrillation: a post hoc ancillary analysis from the AFFIRM trial","volume":"9","author":"Proietti","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"2024062010205619100_bib11","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1016\/j.jacc.2020.01.052","article-title":"Mobile health technology to improve care for patients with atrial fibrillation","volume":"75","author":"Guo","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"2024062010205619100_bib12","article-title":"Mobile health-technology-integrated care for atrial fibrillation: a win ratio analysis from the mAFA-II randomized clinical trial","author":"Romiti","year":"2023","journal-title":"Thromb Haemost"},{"key":"2024062010205619100_bib13","doi-asserted-by":"crossref","first-page":"2916","DOI":"10.1093\/eurheartj\/ehac265","article-title":"A multinational European network to implement integrated care in elderly multimorbid atrial fibrillation patients: the AFFIRMO Consortium","volume":"43","author":"Johnsen","year":"2022","journal-title":"Eur Heart J"},{"key":"2024062010205619100_bib14","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1136\/heartjnl-2018-312977","article-title":"Prevalence and treatment of atrial fibrillation in UK general practice from 2000 to 2016","volume":"105","author":"Adderley","year":"2019","journal-title":"Heart"},{"key":"2024062010205619100_bib15","author":"Principal projection\u2014UK population in age groups"},{"key":"2024062010205619100_bib16","volume-title":"NICE. Health Technology Evaluations: The Manual.","author":"NICE","year":"2022"},{"key":"2024062010205619100_bib17","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1111\/j.1747-4949.2012.00812.x","article-title":"Population-based study of acute- and long-term care costs after stroke in patients with AF","volume":"8","author":"Luengo-Fernandez","year":"2013","journal-title":"Int J Stroke"},{"key":"2024062010205619100_bib18","doi-asserted-by":"crossref","first-page":"367","DOI":"10.2217\/fca-2019-0033","article-title":"Costs of gastrointestinal bleeding events in atrial fibrillation: a UK Clinical Practice Research Datalink study","volume":"15","author":"Ramagopalan","year":"2019","journal-title":"Future Cardiol"},{"key":"2024062010205619100_bib19","volume-title":"Unit Costs of Health and Social Care 2021","author":"Jones","year":"2021."},{"key":"2024062010205619100_bib20","author":"Bank of England Monetary policy"},{"key":"2024062010205619100_bib21","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1093\/ehjqcco\/qcac005","article-title":"Targeted vs. full population screening costs for incident atrial fibrillation and AF-related stroke for a healthy population aged 65 years in the United Kingdom","volume":"8","author":"Burdett","year":"2022","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"2024062010205619100_bib22","doi-asserted-by":"crossref","first-page":"e29408","DOI":"10.2196\/29408","article-title":"Cost-effectiveness of mobile health-based integrated care for atrial fibrillation: model development and data analysis","volume":"24","author":"Luo","year":"2022","journal-title":"J Med Internet Res"},{"key":"2024062010205619100_bib23","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1080\/13696998.2020.1860371","article-title":"Long-term cost-effectiveness of a disease management program for patients with atrial fibrillation compared to standard care\u2014a multi-state survival model based on a randomized controlled trial","volume":"24","author":"Gao","year":"2021","journal-title":"J Med Econ"},{"key":"2024062010205619100_bib24","author":"Size of the Prize and NHS Health Check factsheet"},{"key":"2024062010205619100_bib25","author":"Atrial fibrillation (AF) toolkit: working together to prevent AF-related strokes"},{"key":"2024062010205619100_bib26","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.ahj.2007.03.008","article-title":"Guideline-adherent antithrombotic treatment is associated with improved outcomes compared with undertreatment in high-risk patients with atrial fibrillation. The Euro Heart Survey on Atrial Fibrillation","volume":"153","author":"Nieuwlaat","year":"2007","journal-title":"Am Heart J"},{"key":"2024062010205619100_bib27","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1093\/europace\/euv269","article-title":"Improved outcomes with European Society of Cardiology guideline-adherent antithrombotic treatment in high-risk patients with atrial fibrillation: a report from the EORP-AF General Pilot Registry","volume":"17","author":"Lip","year":"2015","journal-title":"Europace"},{"key":"2024062010205619100_bib28","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1378\/chest.10-2436","article-title":"Prognosis and guideline-adherent antithrombotic treatment in patients with atrial fibrillation and atrial flutter: implications of undertreatment and overtreatment in real-life clinical practice; the Loire Valley Atrial Fibrillation Project","volume":"140","author":"Gorin","year":"2011","journal-title":"Chest"},{"key":"2024062010205619100_bib29","article-title":"Evidence summary for screening for atrial fibrillation in adults: external review against programme appraisal criteria for the UK national screening Committee: UK national screening Committee","author":"King","year":"2019"},{"key":"2024062010205619100_bib30","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1001\/jama.2021.23732","article-title":"Screening for atrial fibrillation: US Preventive Services Task Force recommendation statement","volume":"327","author":"Force","year":"2022","journal-title":"J Am Med Assoc"},{"key":"2024062010205619100_bib31","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1177\/2396987319883160","article-title":"Economic burden of stroke across Europe: a population-based cost analysis","volume":"5","author":"Luengo-Fernandez","year":"2020","journal-title":"Eur Stroke J"},{"key":"2024062010205619100_bib32","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1160\/TH16-11-0876","article-title":"Stroke prevention in atrial fibrillation: past, present and future. Comparing the guidelines and practical decision-making","volume":"117","author":"Lip","year":"2017","journal-title":"Thromb Haemost"}],"container-title":["European Heart Journal - Quality of Care and Clinical Outcomes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ehjqcco\/advance-article-pdf\/doi\/10.1093\/ehjqcco\/qcad055\/51851610\/qcad055.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjqcco\/article-pdf\/10\/4\/326\/58285264\/qcad055.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjqcco\/article-pdf\/10\/4\/326\/58285264\/qcad055.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T10:22:12Z","timestamp":1718878932000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ehjqcco\/article\/10\/4\/326\/7269207"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,11]]},"references-count":32,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,9,11]]},"published-print":{"date-parts":[[2024,6,20]]}},"URL":"https:\/\/doi.org\/10.1093\/ehjqcco\/qcad055","relation":{},"ISSN":["2058-5225","2058-1742"],"issn-type":[{"value":"2058-5225","type":"print"},{"value":"2058-1742","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,6]]},"published":{"date-parts":[[2023,9,11]]}}}